Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Catalyst Pharm Inc (CPRX)

Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,522,624
  • Shares Outstanding, K 119,273
  • Annual Sales, $ 398,200 K
  • Annual Income, $ 71,410 K
  • EBIT $ 211 M
  • EBITDA $ 244 M
  • 60-Month Beta 0.75
  • Price/Sales 6.41
  • Price/Cash Flow 10.40
  • Price/Book 3.84

Options Overview Details

View History
  • Implied Volatility 35.22% ( -0.79%)
  • Historical Volatility 33.26%
  • IV Percentile 22%
  • IV Rank 27.52%
  • IV High 77.22% on 07/10/24
  • IV Low 19.27% on 06/17/24
  • Put/Call Vol Ratio 0.02
  • Today's Volume 46
  • Volume Avg (30-Day) 326
  • Put/Call OI Ratio 0.20
  • Today's Open Interest 4,025
  • Open Int (30-Day) 3,640

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.50
  • Number of Estimates 4
  • High Estimate 0.52
  • Low Estimate 0.48
  • Prior Year 0.49
  • Growth Rate Est. (year over year) +2.04%

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.44 +2.74%
on 11/15/24
24.27 -13.47%
on 11/08/24
-0.02 (-0.10%)
since 10/21/24
3-Month
19.00 +10.53%
on 09/11/24
24.27 -13.47%
on 11/08/24
+0.53 (+2.59%)
since 08/21/24
52-Week
13.00 +61.54%
on 12/12/23
24.27 -13.47%
on 11/08/24
+7.26 (+52.84%)
since 11/21/23

Most Recent Stories

More News
Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences

CPRX : 21.10 (-0.24%)
Catalyst Pharmaceuticals Recognized Among BioSpace 2025 Best Places to Work

CPRX : 21.10 (-0.24%)
Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar and Theravance

For Immediate ReleaseChicago, IL – November 11, 2024 – Today, Zacks Equity Research like Madrigal Pharmaceuticals MDGL, Corcept Therapeutics CORT, Catalyst Pharmaceuticals CPRX, Larimar Therapeutics...

CORT : 57.03 (+1.68%)
TBPH : 9.93 (-0.40%)
MDGL : 320.31 (+1.02%)
LRMR : 5.93 (-2.47%)
CPRX : 21.10 (-0.24%)
5 Small Drug Stocks to Buy as Trump Gets Re-Elected

The drug industry witnessed major policy changes during Joe Biden's four-year term as U.S. President, including the historic Inflation Reduction Act (“IRA”). With Donald Trump’s reelection, the biotech...

CORT : 57.03 (+1.68%)
TBPH : 9.93 (-0.40%)
MDGL : 320.31 (+1.02%)
LRMR : 5.93 (-2.47%)
CPRX : 21.10 (-0.24%)
Catalyst Pharmaceuticals Reports Strong Third Quarter 2024 Financial Results and Provides Corporate Update

CPRX : 21.10 (-0.24%)
Catalyst Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 6, 2024

CPRX : 21.10 (-0.24%)
SRRK Stock Soars as Muscle Disease Drug Meets Phase III Study Goal

Shares of Scholar Rock SRRK skyrocketed 362% on Monday after the company announced positive top-line results from the late-stage study, evaluating the efficacy and safety of its investigational muscle-targeted...

BHVN : 46.31 (-1.11%)
ANIP : 55.10 (+0.91%)
CPRX : 21.10 (-0.24%)
SRRK : 27.91 (+0.18%)
Catalyst Pharmaceuticals Donates $100,000 to the American Red Cross Hurricane Helene Relief Efforts

CPRX : 21.10 (-0.24%)
New Strong Buy Stocks for October 8th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Catalyst Pharmaceuticals CPRX: This commercial-stage biopharmaceutical company which is focused on the development and commercialization...

CRUS : 101.12 (+0.91%)
CRAI : 191.23 (-0.72%)
CPRX : 21.10 (-0.24%)
DXC : 21.28 (+0.52%)
HCI : 109.78 (+1.65%)
2 Incredible Growth Stocks to Buy Hand Over Fist Right Now

These two healthcare stocks may be deeply undervalued.

ETN : 367.68 (+2.00%)
CPRX : 21.10 (-0.24%)
NVAX : 8.07 (+0.12%)
SNY : 47.73 (-0.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Catalyst Pharmaceuticals, Inc. is a development-stage biopharmaceutical company focused on the development and commercialization of therapies targeting rare neurological diseases and disorders, like Lambert-Eaton Myasthenic Syndrome (LEMS), epilepsy and Tourette syndrome. Catalyst in-licensed rights...

See More

Key Turning Points

3rd Resistance Point 22.08
2nd Resistance Point 21.86
1st Resistance Point 21.50
Last Price 21.10
1st Support Level 20.92
2nd Support Level 20.70
3rd Support Level 20.34

See More

52-Week High 24.27
Last Price 21.10
Fibonacci 61.8% 19.96
Fibonacci 50% 18.64
Fibonacci 38.2% 17.31
52-Week Low 13.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar